COMPANY
LifeMine Therapeutics
Timeline
- Trial start I: A Phase I Study to Evaluate LIFE-001 source ↗
Upcoming milestones
- Nov 13, 2026 (ESTIMATED) · I · A Phase I Study to Evaluate LIFE-001 · NCT06904807
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06904807 | A Phase I Study to Evaluate LIFE-001 | I | Recruiting | Apr 7, 2025 | Nov 13, 2026 (estimated) |
Raises and investors new
- InvestorListed in the portfolio of ARCH Venture Partners (captured Oct 12, 2026). portfolio page ↗